Every Hermes Vector story about FDA, newest first. Each one is checked against its sources.
The FDA has approved AbbVie's Juvmo (tavapadon) to treat Parkinson's disease in adults. AbbVie says it is the first selective D1/D5 receptor agonist approved for the condition and expects US availability in October 2026.
The CDC and FDA are investigating a Salmonella outbreak linked to recalled broccoli sprouts from Evergreen Fresh Sprouts of Moyie Springs, Idaho. As of September 24, 32 people in six states were sick.
New CDC guidance dated September 23 recommends an updated COVID-19 vaccine for all adults. Some of the uses it describes fall outside the FDA's approvals, and the agency labels them off-label.
The FDA approved Ultragenyx's one-time gene therapy Fayuvi for children with Sanfilippo syndrome type A, a rare and fatal inherited brain disease. It is the first approved treatment for the condition.
